Reply to thread

Message: <blockquote data-quote="Greg Benage" data-source="post: 7674138" data-attributes="member: 93631">Pretty brutal, but it's hard to say how much of it was the d20 life cycle (rather than Midnight specifically), how much of it was lower-quality supplements compared to the core book, how much of it was the mix of supplements we published, and how much of it was the usual declining sales of supplements. It was a "noisy" time in that segment, so it's hard to draw general conclusions. The core book (and even Second Edition) did very well for FFG, but I expect the company lost money on the supplement line. The pre-orders and print runs declined to, really, an unsustainable level, and by the end of the run, the d20 bubble had popped and they were mostly fodder for $5 sales so the inventory wouldn't be taxed as profit. Of course, performance of the other campaign setting lines (Dragonstar, Dawnforge) was worse. <img src="https://cdn.jsdelivr.net/joypixels/assets/8.0/png/unicode/64/1f609.png" class="smilie smilie--emoji" loading="lazy" width="64" height="64" alt=";)" title="Wink    ;)"  data-smilie="2"data-shortname=";)" /></blockquote>